- Country: Czech Republic
- Summary: Lp for the Treatment of Pulmonary Arterial Hypertension (Pah) Xiv.
- CZT Ref No: 128532893
- Deadline: 13 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 106500000
- Notice Type: Tender
- Document Ref. No.: 686457-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is the regular supply of medicinal products containing the active substance sotatercept (ATC C02KX06) for the treatment of patients in the approved indication of pulmonary arterial hypertension (PAH) according to the SPC valid on the date of submission of bids.
AND.
Doc Title: LP for the treatment of pulmonary arterial hypertension (PAH) XIV. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLp for the Treatment of Pulmonary Arterial Hypertension (Pah) Xiv. - Czech Republic Tender
The INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE, a Government sector organization in Czech Republic, has announced a new tender for Lp for the Treatment of Pulmonary Arterial Hypertension (Pah) Xiv.. This tender is published on CzechRepublicTenders under CZT Ref No: 128532893 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-13.
The estimated tender value is CZK 106500000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
